TABLE OF CONTENTS
Volume 9, Issue 1 (February 2009)
Perspective
The impact of microRNAs and alternative splicing in pharmacogenomics FREE
F Passetti, C G Ferreira and F F Costa
Pharmacogenomics J 9: 1-13; doi:10.1038/tpj.2008.14
Review
Designing pharmacogenetic projects in industry: practical design perspectives from the Industry Pharmacogenomics Working Group FREE
C M Bromley, S Close, N Cohen, R Favis, B Fijal, F Gheyas, W Liu, C Lopez-Correa, A Prokop, J B Singer, A Snapir, A Tchelet, D Wang and D Goldstaub
Pharmacogenomics J 9: 14-22; advance online publication, September 16, 2008; doi:10.1038/tpj.2008.11
Original Articles
Genome-wide approaches to identify pharmacogenetic contributions to adverse drug reactions FREE
M R Nelson, S-A Bacanu, M Mosteller, L Li, C E Bowman, A D Roses, E H Lai and M G Ehm
Pharmacogenomics J 9: 23-33; advance online publication, February 26, 2008; doi:10.1038/tpj.2008.4
The AmpliChip CYP450 test: cytochrome P450 2D6 genotype assessment and phenotype prediction FREE
M C Rebsamen, J Desmeules, Y Daali, A Chiappe, A Diemand, C Rey, J Chabert, P Dayer, D Hochstrasser and M F Rossier
Pharmacogenomics J 9: 34-41; advance online publication, July 1, 2008; doi:10.1038/tpj.2008.7
Global meta-analysis of the C-11377G alteration in the ADIPOQ gene indicates the presence of population-specific effects: challenge for global health initiatives FREE
P E H Schwarz, G W Towers, A van der Merwe, L Perez-Perez, P Rheeder, J Schulze, S R Bornstein, J Licinio, M-L Wong, A E Schutte and A Olckers
Pharmacogenomics J 9: 42-48; advance online publication, March 4, 2008; doi:10.1038/tpj.2008.2
Prediction of CYP3A4 enzyme activity using haplotype tag SNPs in African Americans FREE
M A Perera, R K Thirumaran, N J Cox, S Hanauer, S Das, C Brimer-Cline, V Lamba, E G Schuetz, M J Ratain and A Di Rienzo
Pharmacogenomics J 9: 49-60; advance online publication, September 30, 2008; doi:10.1038/tpj.2008.13
Polymorphisms in the SLC6A4 and HTR2A genes influence treatment outcome following antidepressant therapy FREE
M J V Wilkie, G Smith, R K Day, K Matthews, D Smith, D Blackwood, I C Reid and C R Wolf
Pharmacogenomics J 9: 61-70; advance online publication, February 5, 2008; doi:10.1038/sj.tpj.6500491
DRD4 48 bp VNTR but not 5-HT2C Cys23Ser receptor polymorphism is related to antipsychotic-induced weight gain FREE
J Popp, S Leucht, S Heres and W Steimer
Pharmacogenomics J 9: 71-77; advance online publication, March 11, 2008; doi:10.1038/tpj.2008.5
Variations in the interleukin-1 receptor antagonist gene impact on survival of patients with advanced colorectal cancer FREE
F Graziano, A Ruzzo, E Canestrari, F Loupakis, D Santini, E Rulli, B Humar, N Galluccio, R Bisonni, I Floriani, P Maltese, A Falcone, G Tonini, V Catalano, A Fontana, L Giustini, G Masi, B Vincenzi, P Alessandroni and M Magnani
Pharmacogenomics J 9: 78-84; advance online publication, December 23, 2008; doi:10.1038/tpj.2008.16
